Your browser doesn't support javascript.
loading
Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors.
Atallah, Ehab; Mauro, Michael J; Hochhaus, Andreas; Boquimpani, Carla; Minami, Yosuke; Maheshwari, Vikalp Kumar; Saini, Lovneet; Corbin, Regina; Réa, Delphine.
Affiliation
  • Atallah E; Medical College of Wisconsin, Milwaukee, WI, USA. eatallah@mcw.edu.
  • Mauro MJ; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Hochhaus A; Universitätsklinikum Jena, Jena, Germany.
  • Boquimpani C; HEMORIO, State Institute of Hematology Arthur de Siquiera Cavalcanti, Rio de Janeiro, Brazil.
  • Minami Y; Oncoclínica Centro de Tratamento Oncológico, Rio de Janeiro, Brazil.
  • Maheshwari VK; National Cancer Center Hospital East, Kashiwa, Japan.
  • Saini L; Novartis Healthcare Pvt. Ltd, Hyderabad, India.
  • Corbin R; Novartis Healthcare Pvt. Ltd, Hyderabad, India.
  • Réa D; Novartis Services Inc., East Hanover, NJ, USA.
J Cancer Res Clin Oncol ; 149(9): 6247-6262, 2023 Aug.
Article in En | MEDLINE | ID: mdl-36707445
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Leukemia, Myeloid, Chronic-Phase / Antineoplastic Agents Type of study: Etiology_studies / Guideline Limits: Humans Language: En Journal: J Cancer Res Clin Oncol Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Leukemia, Myeloid, Chronic-Phase / Antineoplastic Agents Type of study: Etiology_studies / Guideline Limits: Humans Language: En Journal: J Cancer Res Clin Oncol Year: 2023 Document type: Article Affiliation country: Country of publication: